AAAAAA

   
Results: 1-8 |
Results: 8
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTCgynaecological cancer co-operative group study
Authors: Duffaud, F van der Burg, MEL Namer, M Vergote, I Willemse, PHB Huinink, WT Guastalla, JP Nooij, MA Kerbrat, P Piccart, M Tumolo, S Favalli, G van der Vange, N Lacave, AJ Wils, J Splinter, TAW Einhorn, N Roozendaal, KJ Rosso, R Vermorken, JB
Citation: F. Duffaud et al., D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTCgynaecological cancer co-operative group study, ANTI-CANC D, 12(2), 2001, pp. 159-162
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study
Authors: Wagenaar, HC Pecorelli, S Vergote, I Curran, D Wagener, DJT Kobierska, A Bolis, G ten Bokkel-Huinink, W Lacave, AJ Madronal, C Forni, M de Oliveira, CF Mangioni, C Nooij, MA Goupil, A Kerbrat, P Marth, C Tumolo, S Herben, MG Zanaboni, F Vermorken, JB
Citation: Hc. Wagenaar et al., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study, EUR J GYN O, 22(3), 2001, pp. 187-193
Stability of patients' preferences for chemotherapy: The impact of experience
Authors: Jansen, SJT Kievit, J Nooij, MA Stiggelbout, AM
Citation: Sjt. Jansen et al., Stability of patients' preferences for chemotherapy: The impact of experience, MED DECIS M, 21(4), 2001, pp. 295-306
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group study
Authors: Wagenaar, HC Colombo, N Vergote, I Hoctin-Boes, G Zanetta, G Pecorelli, S Lacave, AJ van Hoesel, Q Cervantes, A Bolis, G Namer, M Lhomme, C Guastalla, JP Nooij, MA Poveda, A di Palumbo, VS Vermorken, JB
Citation: Hc. Wagenaar et al., Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group study, GYNECOL ONC, 81(3), 2001, pp. 348-354
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
Authors: Jansen, SJT Kievit, J Nooij, MA de Haes, JCJM Overpelt, IME van Slooten, H Maartense, E Stiggelbout, AM
Citation: Sjt. Jansen et al., Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?, BR J CANC, 84(12), 2001, pp. 1577-1585
Response shift in quality of life measurement in early-stage breast cancerpatients undergoing radiotherapy
Authors: Jansen, SJT Stiggelbout, AM Nooij, MA Noordijk, EM Kievit, J
Citation: Sjt. Jansen et al., Response shift in quality of life measurement in early-stage breast cancerpatients undergoing radiotherapy, QUAL LIFE R, 9(6), 2000, pp. 603-615
The effect of individually assessed preference weights on the relationshipbetween holistic utilities and nonpreference-based assessment
Authors: Jansen, SJT Stiggelbout, AM Nooij, MA Kievit, J
Citation: Sjt. Jansen et al., The effect of individually assessed preference weights on the relationshipbetween holistic utilities and nonpreference-based assessment, QUAL LIFE R, 9(5), 2000, pp. 541-557
Unstable preferences: A shift in valuation or an effect of the elicitationprocedure?
Authors: Jansen, SJT Stiggelbout, AM Wakker, PP Nooij, MA Noordijk, EM Kievit, J
Citation: Sjt. Jansen et al., Unstable preferences: A shift in valuation or an effect of the elicitationprocedure?, MED DECIS M, 20(1), 2000, pp. 62-71
Risultati: 1-8 |